CN112778283A - Organic electroluminescent material and device thereof - Google Patents

Organic electroluminescent material and device thereof Download PDF

Info

Publication number
CN112778283A
CN112778283A CN201911084832.5A CN201911084832A CN112778283A CN 112778283 A CN112778283 A CN 112778283A CN 201911084832 A CN201911084832 A CN 201911084832A CN 112778283 A CN112778283 A CN 112778283A
Authority
CN
China
Prior art keywords
substituted
group
unsubstituted
carbon atoms
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911084832.5A
Other languages
Chinese (zh)
Other versions
CN112778283B (en
Inventor
王强
王乐
邝志远
夏传军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Xiahe Technology Co ltd
Original Assignee
Beijing Xiahe Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Xiahe Technology Co ltd filed Critical Beijing Xiahe Technology Co ltd
Priority to CN201911084832.5A priority Critical patent/CN112778283B/en
Publication of CN112778283A publication Critical patent/CN112778283A/en
Application granted granted Critical
Publication of CN112778283B publication Critical patent/CN112778283B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0816Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring comprising Si as a ring atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40Organosilicon compounds, e.g. TIPS pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

An organic electroluminescent material and a device thereof are disclosed. The organic electroluminescent material is a compound with an arylamine substituted indenocarbazole structure, and can be used as a main body material in an electroluminescent device. These novel compounds provide better device performance. Also discloses a compound formula.

Description

Organic electroluminescent material and device thereof
Technical Field
The present invention relates to compounds for use in organic electronic devices, such as organic electroluminescent devices. More particularly, the invention relates to a compound with an arylamine substituted indenocarbazole structure, an organic electroluminescent device containing the compound and a compound formula.
Background
Organic electronic devices include, but are not limited to, the following classes: organic Light Emitting Diodes (OLEDs), organic field effect transistors (O-FETs), Organic Light Emitting Transistors (OLETs), Organic Photovoltaics (OPVs), dye-sensitized solar cells (DSSCs), organic optical detectors, organic photoreceptors, organic field effect devices (OFQDs), light emitting electrochemical cells (LECs), organic laser diodes, and organic plasma light emitting devices.
In 1987, Tang and Van Slyke, by Isman Kodak, reported a two-layer organic electroluminescent device comprising an arylamine hole transport layer and a tris-8-hydroxyquinoline-aluminum layer as an electron transport layer and a light-emitting layer (Applied Physics Letters, 1987,51(12): 913-915). Upon biasing the device, green light is emitted from the device. The invention lays a foundation for the development of modern Organic Light Emitting Diodes (OLEDs). The most advanced OLEDs may comprise multiple layers, such as charge injection and transport layers, charge and exciton blocking layers, and one or more light emitting layers between the cathode and anode. Since OLEDs are a self-emissive solid state device, it offers great potential for display and lighting applications. Furthermore, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications, such as in the fabrication of flexible substrates.
OLEDs can be classified into three different types according to their light emitting mechanisms. The OLEDs invented by Tang and van Slyke are fluorescent OLEDs. It uses only singlet luminescence. The triplet states generated in the device are wasted through the non-radiative decay channel. Therefore, the Internal Quantum Efficiency (IQE) of fluorescent OLEDs is only 25%. This limitation hinders the commercialization of OLEDs. In 1997, Forrest and Thompson reported phosphorescent OLEDs, which use triplet emission from complex-containing heavy metals as emitters. Thus, singlet and triplet states can be harvested, achieving 100% IQE. Due to its high efficiency, the discovery and development of phosphorescent OLEDs directly contributes to the commercialization of Active Matrix OLEDs (AMOLEDs). Recently, Adachi has achieved high efficiency through Thermally Activated Delayed Fluorescence (TADF) of organic compounds. These emitters have a small singlet-triplet gap, making it possible for excitons to return from the triplet state to the singlet state. In TADF devices, triplet excitons are able to generate singlet excitons through reverse intersystem crossing, resulting in high IQE.
OLEDs can also be classified into small molecule and polymer OLEDs depending on the form of the material used. Small molecule refers to any organic or organometallic material that is not a polymer. The molecular weight of small molecules can be large, as long as they have a precise structure. Dendrimers with well-defined structures are considered small molecules. The polymeric OLED comprises a conjugated polymer and a non-conjugated polymer having a pendant light-emitting group. Small molecule OLEDs can become polymer OLEDs if post-polymerization occurs during the fabrication process.
Various OLED manufacturing methods exist. Small molecule OLEDs are typically fabricated by vacuum thermal evaporation. Polymer OLEDs are fabricated by solution processes such as spin coating, ink jet printing and nozzle printing. Small molecule OLEDs can also be made by solution processes if the material can be dissolved or dispersed in a solvent.
The light emitting color of the OLED can be realized by the structural design of the light emitting material. An OLED may comprise one light emitting layer or a plurality of light emitting layers to achieve a desired spectrum. Green, yellow and red OLEDs, phosphorescent materials have been successfully commercialized. Blue phosphorescent devices still have the problems of blue unsaturation, short device lifetime, high operating voltage, and the like. Commercial full-color OLED displays typically employ a hybrid strategy, using either blue fluorescence and phosphorescent yellow, or red and green. At present, the rapid decrease in efficiency of phosphorescent OLEDs at high luminance is still a problem. In addition, it is desirable to have a more saturated emission spectrum, higher efficiency and longer device lifetime.
U.S. Pat. No. 4, 20170077415, 1 discloses compounds having an indenocarbazole unit linked to a quinazoline structure of the general formula
Figure BDA0002262103950000021
The concrete structure is that
Figure BDA0002262103950000022
The use of triarylamine substitution in such compounds by incorporation on the indenocarbazole ring is not disclosed and taught. Further, the compounds reported therein are useful as electron transport materials,the use thereof as a host material is not clear.
CN108779072A discloses a compound with an indenocarbazole unit linked quinazoline structure, which has the following general formula
Figure BDA0002262103950000023
The concrete structure is that
Figure BDA0002262103950000024
However, the application of the triarylamine substitution on the indenocarbazole ring in the compound is not disclosed and taught, and the disclosed compound is used as a main material for an organic electronic device and has higher voltage.
U.S. Pat. No. 4, 20180006237, 1 discloses compounds having a quinazolino group attached to an indenocarbazole unit and having triarylamine substitution introduced in the carbazole moiety, having the general formula
Figure BDA0002262103950000025
The concrete structure is that
Figure BDA0002262103950000026
However, the application of triarylamine substitution in the indeno ring part of the indenocarbazole ring is not disclosed and taught, and the disclosed compound is used as a main material for organic electronic devices with higher voltage.
CN105849107A discloses a compound with an indenocarbazole unit linked quinazoline structure, which has the following general formula
Figure BDA0002262103950000027
The concrete structure is that
Figure BDA0002262103950000028
The use of triarylamine substitution in such compounds by incorporation on the indenocarbazole ring is not disclosed and taught.
These documents disclose compounds having an indenocarbazole ring as a core structure, and have a nitrogen heterocyclic ring substitution introduced into carbazole. The inventor of the invention finds that a novel bipolar compound is constructed by taking an indenocarbazole ring as a core, introducing nitrogen heterocycle with excellent electron transport capability on carbazole and introducing triarylamine with excellent hole transport capability on indene for substitution, and when the bipolar compound is used in an organic light-emitting device, the bipolar compound can provide better device performance.
Disclosure of Invention
The present invention aims to provide a series of compounds having a novel indenocarbazole structure, which are useful as host materials in organic electroluminescent devices. The novel compounds are applied to organic light-emitting devices and can provide better device performance.
According to one embodiment of the present invention, a compound comprising the structure of formula 1 is disclosed:
Figure BDA0002262103950000031
wherein, Y1To Y4Any two of which are selected from N, one of the remaining two is selected from C, and the other is selected from CRy
Wherein, Y5To Y8Each independently selected from N or CRy
Wherein L isyIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein, X1To X4Each independently selected from N or CRx1;X5To X8Each independently selected from N, C or CRx2Wherein X is5To X8Two adjacent of them are C, and are arbitrarily connected with two positions shown in formula 1A;
Figure BDA0002262103950000032
wherein L isxIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted arylene group having 3 to 30 carbon atomsThe heteroarylene group of (a);
wherein Z is1To Z4Independently selected from N, C or CRz
Wherein each occurrence of Ar, the same or different, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms;
wherein the adjacent substituents Rx1Can be optionally linked to form a ring;
wherein R isx1,Rx2,Ry,RzAnd R is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof.
According to another embodiment of the present invention, there is also disclosed an electroluminescent device comprising an anode, a cathode, and an organic layer disposed between the anode and the cathode, the organic layer comprising the compound, the compound comprising the structure of formula 1.
According to another embodiment of the present invention, there is also disclosed a compound formulation comprising the compound, the compound comprising the structure of formula 1.
The novel compound with the indenocarbazole structure can be used as a main body material in an electroluminescent device. The novel bipolar compounds are applied to organic light-emitting devices, can effectively balance carriers in a light-emitting layer, and provide better device performance, such as lower driving voltage.
Drawings
FIG. 1 is a schematic representation of an organic light emitting device that can contain the compounds and compound formulations disclosed herein.
Fig. 2 is a schematic view of another organic light emitting device that can contain compounds and compound formulations disclosed herein.
Detailed Description
OLEDs can be fabricated on a variety of substrates, such as glass, plastic, and metal. Fig. 1 schematically, but without limitation, illustrates an organic light emitting device 100. The figures are not necessarily to scale, and some of the layer structures in the figures may be omitted as desired. The device 100 may include a substrate 101, an anode 110, a hole injection layer 120, a hole transport layer 130, an electron blocking layer 140, an emissive layer 150, a hole blocking layer 160, an electron transport layer 170, an electron injection layer 180, and a cathode 190. The device 100 may be fabricated by sequentially depositing the described layers. The nature and function of the layers, as well as exemplary materials, are described in more detail in U.S. patent US7,279,704B2, columns 6-10, which is incorporated herein by reference in its entirety.
There are more instances of each of these layers. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14m-MTDATA of TCNQ, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of host materials are disclosed in U.S. patent No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes including cathodes having, for example, MgA composite cathode of a thin layer of a metal such as Ag and an overlying transparent, conductive, sputter-deposited ITO layer. The principles and use of barrier layers are described in more detail in U.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of implant layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of a protective layer can be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
The above-described hierarchical structure is provided via non-limiting embodiments. The function of the OLED may be achieved by combining the various layers described above, or some layers may be omitted entirely. It may also include other layers not explicitly described. Within each layer, a single material or a mixture of materials may be used to achieve optimal performance. Any functional layer may comprise several sub-layers. For example, the light emitting layer may have two layers of different light emitting materials to achieve a desired light emission spectrum.
In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. The organic layer may include one or more layers.
The OLED also requires an encapsulation layer, as shown in fig. 2, which is an exemplary, non-limiting illustration of an organic light emitting device 200, which differs from fig. 1 in that an encapsulation layer 102 may also be included over the cathode 190 to protect against harmful substances from the environment, such as moisture and oxygen. Any material capable of providing an encapsulation function may be used as the encapsulation layer, such as glass or a hybrid organic-inorganic layer. The encapsulation layer should be placed directly or indirectly outside the OLED device. Multilayer film encapsulation is described in U.S. patent US7,968,146B2, the entire contents of which are incorporated herein by reference.
Devices manufactured according to embodiments of the present invention may be incorporated into various consumer products having one or more electronic component modules (or units) of the device. Some examples of such consumer products include flat panel displays, monitors, medical monitors, televisions, billboards, lights for indoor or outdoor lighting and/or signaling, head-up displays, fully or partially transparent displays, flexible displays, smart phones, tablet computers, tablet handsets, wearable devices, smart watches, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicle displays, and tail lights.
The materials and structures described herein may also be used in other organic electronic devices as previously listed.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed on" a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode can be described as being "disposed on" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand directly contributes to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
It is believed that the Internal Quantum Efficiency (IQE) of fluorescent OLEDs can be limited by delaying fluorescence beyond 25% spin statistics. Delayed fluorescence can generally be divided into two types, i.e., P-type delayed fluorescence and E-type delayed fluorescence. P-type delayed fluorescence results from triplet-triplet annihilation (TTA).
On the other hand, E-type delayed fluorescence does not depend on collision of two triplet states, but on conversion between triplet and singlet excited states. Compounds capable of producing E-type delayed fluorescence need to have a very small mono-triplet gap in order to switch between energy states. Thermal energy can activate a transition from a triplet state back to a singlet state. This type of delayed fluorescence is also known as Thermally Activated Delayed Fluorescence (TADF). A significant feature of TADF is that the retardation component increases with increasing temperature. If the reverse intersystem crossing (IRISC) rate is fast enough to minimize non-radiative decay from the triplet state, then the fraction of the backfill singlet excited state may reach 75%. The total singlet fraction may be 100%, far exceeding 25% of the spin statistics of the electrogenerated excitons.
The delayed fluorescence characteristic of type E can be found in excited complex systems or in single compounds. Without being bound by theory, it is believed that E-type delayed fluorescence requires the light emitting material to have a small mono-triplet energy gap (Δ Ε)S-T). Organic non-metal containing donor-acceptor emissive materials may be able to achieve this. The emission of these materials is generally characterized as donor-acceptor Charge Transfer (CT) type emission. Spatial separation of HOMO from LUMO in these donor-acceptor type compounds generally results in small Δ ES-T. These states may include CT states. Generally, donor-acceptor light emitting materials are constructed by linking an electron donor moiety (e.g., an amino or carbazole derivative) to an electron acceptor moiety (e.g., a six-membered, N-containing, aromatic ring).
Definitions for substituent terms
Halogen or halide-as used herein, includes fluorine, chlorine, bromine and iodine.
Alkyl-comprises both straight and branched chain alkyl groups. Examples of alkyl groups include methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, neopentyl, 1-methylpentyl, 2-methylpentyl, 1-pentylhexyl, 1-butylpentyl, 1-heptyloctyl, 3-methylpentyl. In addition, the alkyl group may be optionally substituted. The carbons in the alkyl chain may be substituted with other heteroatoms. Among the above, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl and neopentyl are preferable.
Cycloalkyl-as used herein, comprises a cyclic alkyl group. Preferred cycloalkyl groups are those containing 4 to 10 ring carbon atoms and include cyclobutyl, cyclopentyl, cyclohexyl, 4-methylcyclohexyl, 4, 4-dimethylcyclohexyl, 1-adamantyl, 2-adamantyl, 1-norbornyl, 2-norbornyl and the like. In addition, the cycloalkyl group may be optionally substituted. The carbon in the ring may be substituted with other heteroatoms.
Alkenyl-as used herein, encompasses both straight and branched chain olefinic groups. Preferred alkenyl groups are those containing 2 to 15 carbon atoms. Examples of the alkenyl group include a vinyl group, an allyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a1, 3-butadienyl group, a 1-methylvinyl group, a styryl group, a 2, 2-diphenylvinyl group, a 1-methylallyl group, a1, 1-dimethylallyl group, a 2-methylallyl group, a 1-phenylallyl group, a 3, 3-diphenylallyl group, a1, 2-dimethylallyl group, a 1-phenyl-1-butenyl group and a 3-phenyl-1-butenyl group. In addition, alkenyl groups may be optionally substituted.
Alkynyl-as used herein, straight and branched alkynyl groups are contemplated. Preferred alkynyl groups are those containing 2 to 15 carbon atoms. In addition, alkynyl groups may be optionally substituted.
Aryl or aromatic-as used herein, non-fused and fused systems are contemplated. Preferred aryl groups are those containing from 6 to 60 carbon atoms, more preferably from 6 to 20 carbon atoms, and even more preferably from 6 to 12 carbon atoms. Examples of aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chicory, perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted. Examples of non-fused aryl groups include phenyl, biphenyl-2-yl, biphenyl-3-yl, biphenyl-4-yl, p-terphenyl-4-yl, p-terphenyl-3-yl, p-triphenyl-2-yl, m-terphenyl-4-yl, m-terphenyl-3-yl, m-terphenyl-2-yl, o-tolyl, m-tolyl, p-tolyl, p- (2-phenylpropyl) phenyl, 4 '-methyldiphenyl, 4' -tert-butyl-p-terphenyl-4-yl, o-cumyl, m-cumyl, p-cumyl, 2, 3-xylyl, 3, 4-xylyl, 2, 5-xylyl, mesityl and m-quaterphenyl.
Heterocyclyl or heterocyclic-as used herein, aromatic and non-aromatic cyclic groups are contemplated. Heteroaryl also refers to heteroaryl. Preferred non-aromatic heterocyclic groups are those containing 3 to 7 ring atoms, which include at least one heteroatom such as nitrogen, oxygen and sulfur. The heterocyclic group may also be an aromatic heterocyclic group having at least one hetero atom selected from a nitrogen atom, an oxygen atom, a sulfur atom and a selenium atom.
Heteroaryl-as used herein, non-fused and fused heteroaromatic groups are contemplated which may contain 1 to 5 heteroatoms. Preferred heteroaryl groups are those containing from 3 to 30 carbon atoms, more preferably from 3 to 20 carbon atoms, more preferably from 3 to 12 carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridine indole, pyrrolopyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, bisoxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indoline, benzimidazole, indazole, indenozine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, benzothienopyridine, thienobipyridine, benzothiophenopyridine, cinnolinopyrimidine, selenobenzodipyridine, selenobenzene, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1, 2-azaborine, 1, 3-azaborine, 1, 4-azaborine, borazole, and aza analogues thereof. In addition, the heteroaryl group may be optionally substituted.
Alkoxy-is represented by-O-alkyl. Examples and preferred examples of the alkyl group are the same as those described above. Examples of the alkoxy group having 1 to 20 carbon atoms, preferably 1 to 6 carbon atoms include methoxy, ethoxy, propoxy, butoxy, pentyloxy and hexyloxy. The alkoxy group having 3 or more carbon atoms may be linear, cyclic or branched.
Aryloxy-is represented by-O-aryl or-O-heteroaryl. Examples and preferred examples of aryl and heteroaryl groups are the same as described above. Examples of the aryloxy group having 6 to 40 carbon atoms include a phenoxy group and a biphenyloxy group.
Aralkyl-as used herein, an alkyl group having an aryl substituent. In addition, the aralkyl group may be optionally substituted. Examples of the aralkyl group include benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl, 2-phenylisopropyl, phenyl tert-butyl, α -naphthylmethyl, 1- α -naphthylethyl, 2- α -naphthylethyl, 1- α -naphthylisopropyl, 2- α -naphthylisopropyl, β -naphthylmethyl, 1- β -naphthylethyl, 2- β -naphthylethyl, 1- β -naphthylisopropyl, 2- β -naphthylisopropyl, p-methylbenzyl, m-methylbenzyl, o-methylbenzyl, p-chlorobenzyl, m-chlorobenzyl, o-chlorobenzyl, p-bromobenzyl, m-bromobenzyl, o-bromobenzyl, p-iodobenzyl, m-iodobenzyl, o-iodobenzyl, p-hydroxybenzyl, m-hydroxybenzyl, o-hydroxybenzyl, p-aminobenzyl, m-aminobenzyl, o-aminobenzyl, p-nitrobenzyl, m-nitrobenzyl, o-nitrobenzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-2-hydroxy-2-phenylisopropyl and 1-chloro-2-phenylisopropyl. Among the above, benzyl, p-cyanobenzyl, m-cyanobenzyl, o-cyanobenzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylisopropyl and 2-phenylisopropyl are preferable.
The term "aza" in aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more C-H groups in the corresponding aromatic moiety are replaced by a nitrogen atom. For example, azatriphenylenes include dibenzo [ f, h ] quinoxalines, dibenzo [ f, h ] quinolines, and other analogs having two or more nitrogens in the ring system. Other nitrogen analogs of the above-described aza derivatives may be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed within the terms described herein.
In this disclosure, unless otherwise defined, when any one of the terms in the group consisting of: substituted alkyl, substituted cycloalkyl, substituted heteroalkyl, substituted aralkyl, substituted alkoxy, substituted aryloxy, substituted alkenyl, substituted aryl, substituted heteroaryl, substituted alkylsilyl, substituted arylsilyl, substituted amine, substituted acyl, substituted carbonyl, substituted carboxylic acid, substituted ester, substituted cyano, substituted isocyano, substituted sulfanyl, substituted sulfinyl, substituted sulfonyl, substituted phosphino, meaning alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, alkenyl, aryl, heteroaryl, alkylsilyl, arylsilyl, amine, acyl, carbonyl, carboxylic acid, ester, cyano, isocyano, sulfanyl, sulfinyl, sulfonyl and phosphino, any of which may be substituted by one or more groups selected from deuterium, unsubstituted alkyl having 1 to 20 carbon atoms, unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, unsubstituted heteroalkyl having 1 to 20 carbon atoms, unsubstituted aralkyl having 7 to 30 carbon atoms, unsubstituted alkoxy having 1 to 20 carbon atoms, unsubstituted aryloxy having 6 to 30 carbon atoms, unsubstituted alkenyl having 2 to 20 carbon atoms, unsubstituted aryl having 6 to 30 carbon atoms, unsubstituted heteroaryl having 3 to 30 carbon atoms, unsubstituted alkylsilyl having 3 to 20 carbon atoms, unsubstituted arylsilyl having 6 to 20 carbon atoms, unsubstituted amine having 0 to 20 carbon atoms, acyl, carbonyl, carboxylic acid group, ester group, cyano group, isocyano group, sulfanyl group, sulfinyl group, sulfonyl group, phosphino group, and combinations thereof.
It will be understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name may be written depending on whether it is a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or depending on whether it is an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different ways of specifying substituents or linking fragments are considered to be equivalent.
In the compounds mentioned in the present disclosure, a hydrogen atom may be partially or completely replaced by deuterium. Other atoms such as carbon and nitrogen may also be replaced by their other stable isotopes. Substitution of other stable isotopes in the compounds may be preferred because it enhances the efficiency and stability of the device.
In the compounds mentioned in the present disclosure, polysubstitution is meant to encompass disubstituted substitutions up to the maximum range of available substitutions. When a substituent in a compound mentioned in the present disclosure represents multiple substitution (including di-substitution, tri-substitution, tetra-substitution, etc.), that is, it means that the substituent may exist at a plurality of available substitution positions on its connecting structure, and the substituent existing at each of the plurality of available substitution positions may be the same structure or different structures.
In the compounds mentioned in the present disclosure, adjacent substituents in the compounds cannot be linked to form a ring unless specifically defined, for example, adjacent substituents can be optionally linked to form a ring. In the compounds mentioned in the present disclosure, adjacent substituents can be optionally linked to form a ring, including both the case where adjacent substituents may be linked to form a ring and the case where adjacent substituents are not linked to form a ring. When adjacent substituents can optionally be joined to form a ring, the ring formed can be monocyclic or polycyclic, as well as alicyclic, heteroalicyclic, aromatic or heteroaromatic rings. In this expression, adjacent substituents may refer to substituents bonded to the same atom, substituents bonded to carbon atoms directly bonded to each other, or substituents bonded to carbon atoms further away. Preferably, adjacent substituents refer to substituents bonded to the same carbon atom as well as substituents bonded to carbon atoms directly bonded to each other.
The expression that adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to the same carbon atom are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002262103950000071
the expression that adjacent substituents can optionally be linked to form a ring is also intended to mean that two substituents bonded to carbon atoms directly bonded to each other are linked to each other by a chemical bond to form a ring, which can be exemplified by the following formula:
Figure BDA0002262103950000072
further, the expression that adjacent substituents can be optionally connected to form a ring is also intended to be taken to mean that, in the case where one of two substituents bonded to carbon atoms directly bonded to each other represents hydrogen, the second substituent is bonded at a position to which the hydrogen atom is bonded, thereby forming a ring. This is exemplified by the following equation:
Figure BDA0002262103950000081
according to one embodiment of the present invention, a compound comprising the structure of formula 1 is disclosed:
Figure BDA0002262103950000082
wherein, Y1To Y4Any two of which are selected from N, one of the remaining two is selected from C, and the other is selected from CRy
Wherein, Y5To Y8Each independently selected from N or CRy
Wherein L isyIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein, X1To X4Each independently selected from N or CRx1;X5To X8Each independently selected from N, C or CRx2;X5To X8Two of them are adjacent to each other and are randomly connected with the positions shown by two in the formula 1A;
Figure BDA0002262103950000083
wherein L isxIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein Z is1To Z4Each independently selected from N, C or CRz
Wherein each occurrence of Ar, the same or different, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms;
wherein the adjacent substituents Rx1Can be optionally linked to form a ring;
wherein R isx1,Rx2,Ry,RzAnd R is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0-20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, cyano groups, isocyano groups, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof.
According to one embodiment of the present invention, the compound is selected from the group consisting of the following formulas 2-1 to 2-6:
Figure BDA0002262103950000091
Figure BDA0002262103950000101
wherein, Y1To Y8,X1To X8,Z1To Z4,R,Ar,LxAnd LyHaving the same limitation as in formula 1 and formula 1A。
According to one embodiment of the present invention, the compound is selected from the group consisting of the following formulas 2-7 to 2-12:
Figure BDA0002262103950000111
Figure BDA0002262103950000121
wherein, Y1,Y5To Y8,X1To X8,Z1To Z4,R,Ar,LxAnd LyHaving the same limitations as in formula 1 and formula 1A.
According to an embodiment of the invention, wherein Y1,Y5To Y8Each independently selected from CRyWherein R isyEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
According to an embodiment of the invention, wherein X1To X4Each independently selected from CRx1Wherein X is5-X8Two of which are adjacent and selected from C, the remaining two are each independently selected from CRx2Wherein R isx1And Rx2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
According to an embodiment of the invention, wherein Z1To Z4One of which is selected from C and the others are each independently selected from N or CRzWherein R iszEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
According to an embodiment of the invention, wherein Y1,Y5To Y8Each independently selected from CRy
X1To X4Each independently selected from CRX1,X5-X8Two of them are adjacent and selected from C, and the other two are each independently selected from CRX2
Z1To Z4One of which is selected from C and the others are each independently selected from CRz
Ry,RX1,RX2And RzThe same or different at each occurrence is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
According to an embodiment of the invention, wherein LxAnd LyEach independently selected from a single bond, a substituted or unsubstituted arylene group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 12 carbon atoms.
According to an embodiment of the invention, wherein LxAnd LyEach independently selected from a single bond, or a substituted or unsubstituted phenylene group.
According to one embodiment of the invention, wherein R, the same or different at each occurrence, is a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, and combinations thereof; preferably, R is selected, identically or differently on each occurrence, from the group consisting of: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, phenyl, and combinations thereof.
According to one embodiment of the invention, wherein Ar is selected, identically or differently at each occurrence, from the group consisting of: a substituted or unsubstituted phenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzothiapyrrolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, and combinations thereof.
According to one embodiment of the invention, wherein Ar is selected, identically or differently at each occurrence, from the group consisting of:
a substituted or unsubstituted phenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzothiapyrrolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted dibenzoselenophenyl group, and combinations thereof; preferably, Ar is selected, identically or differently at each occurrence, from the group consisting of: phenyl, biphenyl, pyridine, cyanophenyl, fluorenyl, dimethylfluorenyl, diphenylfluorenyl, carbazolyl, phenylcarbazolyl, dibenzothiapyrrolyl, dimethyldibenzothiapyrrolyl, diphenyldibenzothiapyrrolyl, biphenyl, terphenyl, phenanthrenyl, triphenylene, spirobifluorenyl, dibenzofuranyl, dibenzothiophenyl, dibenzoselenophenyl, azadibenzofuranyl, azadibenzothiophenyl, azadibenzoselenophenyl, and combinations thereof.
According to one embodiment of the present invention, the compound is selected from the group consisting of compound 1 to compound 567, wherein the specific structures of compound 1 to compound 567 are set forth in claim 11.
According to an embodiment of the present invention, there is also disclosed an electroluminescent device, including:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and the cathode, the organic layer comprising the compound, the compound comprising a structure represented by formula 1:
Figure BDA0002262103950000141
wherein, Y1To Y4Any two of which are selected from N, one of the remaining two is selected from C, and the other is selected from CRy
Wherein, Y5To Y8Each independently selected from N or CRy
Wherein L isyIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein, X1To X4Each independently selected from N or CRx1;X5To X8Each independently selected from N, C or CRx2;X5To X8Two of them are adjacent to each other and are randomly connected with the positions shown by two in the formula 1A;
Figure BDA0002262103950000142
wherein L isxIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein Z is1To Z4Each independently selected from N, C or CRz
Wherein each occurrence of Ar, the same or different, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms;
wherein the adjacent substituents Rx1Optionally joined to form a ring;
wherein R isx1,Rx2,Ry,RzAnd R is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl having 2 to 20 carbon atoms, substituted or unsubstituted aryl having 6 to 30 carbon atomsSubstituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl having 6 to 20 carbon atoms, substituted or unsubstituted amine having 0 to 20 carbon atoms, acyl, carbonyl, carboxylic acid group, ester group, cyano, isocyano, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
According to one embodiment of the present invention, in the device, the organic layer is a light emitting layer, and the compound is a host material.
According to an embodiment of the invention, in the device, the organic layer further comprises a phosphorescent light emitting material.
According to one embodiment of the invention, in the device, the phosphorescent light emitting material is a metal complex having at least one ligand comprising the structure of any one of:
Figure BDA0002262103950000151
wherein the content of the first and second substances,
Xbselected from the group consisting of: o, S, Se, NRN1And CRC1RC2
XcAnd XdEach independently selected from the group consisting of: o, S, Se, NRN2
Ra,Rb,RcMay represent mono-, poly-, or unsubstituted, and may be the same or different at each occurrence;
Ra,Rb,Rc,RN1,RN2,RC1and RC2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl having 7 to 30 carbon atoms, substituted or unsubstitutedSubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, nitriles, isonitrile, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
in the ligand structure, adjacent substituents can optionally be linked to form a ring.
In this example, the expression that adjacent substituents in the ligand structure can optionally be linked to form a ring is intended to be taken to mean that adjacent substituents in the ligand structure can optionally be linked to each other by a chemical bond, such as substituent RaAnd RbOf a substituent RaAnd RcOf a substituent RbAnd RcOf a substituent RC1And RC2And, when the substituent R isa、RbAnd/or RcWhen multiple substitution is indicated, two adjacent substituents RaBetween, adjacent two substituents RbBetween, adjacent two substituents RcIn the meantime. Furthermore, it is obvious to a person skilled in the art that adjacent substituents R in the ligand structurea、Rb、Rc、RN1,RN2,RC1And RC2May not be connected therebetween.
According to one embodiment of the present invention, the device, wherein the phosphorescent light emitting material is Ir, Pt or Os complex.
According to one embodiment of the present invention, the device, wherein the phosphorescent light emitting material is an Ir complex and has Ir (L)a)(Lb)(Lc) The structure of (1); wherein L isa,LbAnd LcLigands selected, identically or differently, from any of the above.
According to an embodiment of the invention, in the device, wherein the phosphorescent light emitting material is selected from the group consisting of:
Figure BDA0002262103950000152
Figure BDA0002262103950000161
wherein, XfEach occurrence, the same or different, is selected from the group consisting of: o, S, Se, NRN3,CRC3RC4
Wherein, XeSelected, identically or differently at each occurrence, from being CRdOr N;
Ra,Rband RcMay represent mono-, poly-, or unsubstituted, and may be the same or different at each occurrence;
Ra,Rb,Rc,Rd,RN3,RC3and RC4Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, nitriles, isonitriles, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof;
adjacent substituents can optionally be joined to form a ring.
In this example, the expression that adjacent substituents in the ligand structure can optionally be linked to form a ring is intended to be taken to mean that adjacent substituents in the ligand structure can optionally be linked to each other by a chemical bond, such as substituent RaAnd RbOf a substituent RaAnd RcOf a substituent RbAnd RcOf a substituent RdAnd RbOf a substituent RC3And RC4And, when the substituent R isa、RbAnd/or RcWhen multiple substitution is indicated, two adjacent substituents RaBetween, adjacent two substituents RbBetween, adjacent two substituents RcIn the meantime. Furthermore, it is obvious to a person skilled in the art that adjacent substituents R in the ligand structurea、Rb、Rc、Rd、RN3、RC3And RC4May not be connected therebetween.
According to another embodiment of the present invention, there is also disclosed a compound formulation comprising the compound, the compound comprising the structure represented by formula 1. The specific structure of the compound is shown in any one of the embodiments.
In combination with other materials
The materials described herein for use in particular layers in an organic light emitting device may be used in combination with various other materials present in the device. Combinations of these materials are described in detail in U.S. patent application Ser. No. 0132-0161, paragraphs 2016/0359122A1, which are incorporated herein by reference in their entirety. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
Materials described herein as being useful for particular layers in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the materials disclosed herein may be used in conjunction with a variety of light emitting dopants, hosts, transport layers, barrier layers, injection layers, electrodes, and other layers that may be present. Combinations of these materials are described in detail in U.S. patent application US2015/0349273a1, paragraphs 0080-0101, the entire contents of which are incorporated herein by reference. The materials described or referenced therein are non-limiting examples of materials that may be used in combination with the compounds disclosed herein, and one skilled in the art can readily review the literature to identify other materials that may be used in combination.
In the examples of material synthesis, all reactions were carried out under nitrogen unless otherwise stated. All reaction solvents were anhydrous and used as received from commercial sources. The synthesis product is subjected to structural validation and characterization using one or more equipment conventional in the art (including, but not limited to, Bruker's nuclear magnetic resonance apparatus, Shimadzu's liquid chromatograph-mass spectrometer, gas chromatograph-mass spectrometer, differential scanning calorimeter, Shanghai prism-based fluorescence spectrophotometer, Wuhan Corset's electrochemical workstation, Anhui Beidek's sublimator, etc.) in a manner well known to those skilled in the art. In an embodiment of the device, the device characteristics are also tested using equipment conventional in the art (including, but not limited to, an evaporator manufactured by Anttrom engineering, an optical test system manufactured by Fushida, Suzhou, an ellipsometer manufactured by Beijing Mass., etc.) in a manner well known to those skilled in the art. Since the relevant contents of the above-mentioned device usage, testing method, etc. are known to those skilled in the art, the inherent data of the sample can be obtained with certainty and without being affected, and therefore, the relevant contents are not described in detail in this patent.
Materials synthesis example:
the preparation method of the compound of the present invention is not limited, and the following compounds are typically but not limited to, and the synthetic route and the preparation method thereof are as follows:
synthesis example 1: synthesis of Compound 7
Step 1: synthesis of intermediate 7-1:
Figure BDA0002262103950000171
under nitrogen protection, 2-bromo-7-iodo-9, 9-dimethylfluorene (9g, 22.6mmol), aniline (2.1g, 22.6mmol), palladium acetate (51mg, 3mmol),4, 5-bis-diphenylphosphine-9, 9-dimethylxanthene (266mg, 3mmol), sodium tert-butoxide (4.4g, 45.2mmol), and toluene (200mL) were added to a three-necked flask and reacted at 70 ℃ for 16 hours. After completion of the reaction, it was cooled to room temperature, diluted with water, and the mixture was extracted with ethyl acetate, the organic phase was washed with water, concentrated to remove the solvent, and purified by column chromatography (PE/DCM ═ 5/1) to give 7-1(7g, yield: 85%) as a white solid.
Step 2: synthesis of intermediate 7-2:
Figure BDA0002262103950000172
7-1(7g, 19.28mmol), palladium acetate (2.1g, 9.6mmol), potassium carbonate (2.6g, 19.38mmol) and pivalic acid (50mL) were added to a three-necked flask under nitrogen protection and reacted at 140 ℃ for 16 h. Cooled to room temperature, diluted with water, the mixture was extracted with ethyl acetate, the organic phase was washed with water and concentrated to remove the solvent, and purified by column chromatography (PE/DCM ═ 2:1) to give 7-2(2.5g, yield: 66%) as a white solid.
And step 3: synthesis of intermediate 7-3:
Figure BDA0002262103950000173
7-2(2.5g, 6.9mmol), sodium hydride (0.32g, 13.8mmol), 2-chloro-4-phenyl-quinazoline (2500mg, 10.38mmol), N-dimethylformamide (130mL) were added to a three-necked flask under nitrogen and reacted at room temperature for 5 h. After completion of the reaction, water was added to dilute, the mixture was extracted with dichloromethane, the organic phase was washed with water, concentrated to remove the solvent, and purified by column chromatography (PE/DCM ═ 3/1) to obtain 7-3(3.5g, yield: 58%) as a yellow solid.
And 4, step 4: synthesis of Compound 7
Figure BDA0002262103950000181
7-3(3.5g, 6.2mmol), 7-5(1.7g, 6.2mmol), tris (dibenzylideneacetone) dipalladium (56mg, 0.062mmol), 2-dicyclohexylphosphine-2 ',6' -dimethoxybiphenyl (50mg, 0.124mmol), sodium tert-butoxide (1.2g, 12.4mmol), xylene (80mL) were added to a three-necked flask under nitrogen and reacted at 120 ℃ for 16 h. After completion of the reaction, it was cooled to room temperature, diluted with water, and the mixture was extracted with toluene, the organic phase was washed with water, concentrated to remove the solvent, and purified by column chromatography (PE/DCM ═ 5/1) as a yellow solid compound 7(2.1g, yield: 42%). The product was identified as the target product and had a molecular weight of 806.
Device embodiments
Example 1
First, a glass substrate, having an Indium Tin Oxide (ITO) anode 80nm thick, was cleaned and then treated with oxygen plasma and UV ozone. After treatment, the substrate was dried in a glove box to remove moisture. The substrate is then mounted on a substrate holder and loaded into a vacuum chamber. The organic layer specified below was in a vacuum of about 10 degrees-8In the case of torr, the evaporation was performed by thermal vacuum evaporation at a rate of 0.2 to 2 angstroms/second in turn on an ITO anode. Compound HI was used as Hole Injection Layer (HIL). The compound HT is used as a Hole Transport Layer (HTL). Compound EB was used as an Electron Blocking Layer (EBL). Then compound RD (2%) was doped in compound 7 of the present invention and co-evaporated to serve as the light emitting layer (EML). Compound HB was used as a Hole Blocking Layer (HBL). On the hole blocking layer, compound ET and 8-hydroxyquinoline-lithium (Liq) were co-evaporated as an Electron Transport Layer (ETL). Finally, 8-hydroxyquinoline-lithium (Liq) was evaporated to a thickness of 1nm as an electron injection layer, and 120nm of aluminum as a cathode. The device was then transferred back to the glove box and encapsulated with a glass lid and moisture absorber to complete the device.
Comparative example 1
Comparative example 1 was prepared in the same manner as in example 1 except that compound a was used in place of compound 7 of the present invention in the light-emitting layer (EML).
The detailed device portion layer structures and thicknesses are shown in the following table. Wherein more than one layer of the materials used is obtained by doping different compounds in the stated weight ratios.
TABLE 1 device Structure
Figure BDA0002262103950000182
The material structure used in the device is as follows:
Figure BDA0002262103950000191
table 2 shows the values at 1000cd/m2Measured λ max, voltage (V) and CIE data.
TABLE 2 device data
Device ID CIE(x,y) λmax(nm) Voltage(V)
Example 1 0.685,0.314 626 2.92
Comparative example 1 0.683,0.317 625 4.92
Discussion:
example 1 and comparative example 1 each used compound 7 and compound a as the host material. As shown by the data in table 2, CIE, λ max are similar. The driving voltage of example 1 was 2.9V, and the driving voltage of comparative example 1 was 4.92V, and the driving voltage of example 1 was reduced by 40% compared to comparative example 1. Data show that the compound containing the structure of the formula 1 introduces nitrogen heterocycle with excellent electron transport capability on carbazole, introduces triarylamine with excellent hole transport capability on indene for substitution, constructs a bipolar compound, and enables the structure to simultaneously have excellent hole transport capability and electron transport capability, thereby obtaining low-voltage performance in devices.
It should be understood that the various embodiments described herein are illustrative only and are not intended to limit the scope of the invention. Thus, the invention as claimed may include variations from the specific embodiments and preferred embodiments described herein, as will be apparent to those skilled in the art. Many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the present invention. It should be understood that various theories as to why the invention works are not intended to be limiting.

Claims (16)

1. A compound comprising the structure of formula 1:
Figure FDA0002262103940000011
wherein, Y1To Y4Any two of which are selected from N, one of the remaining two is selected from C, and the other is selected from CRy
Wherein, Y5To Y8Each independently selected from N or CRy
Wherein L isyIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted arylene group having 3 to 30 carbon atomsA heteroarylene group;
wherein, X1To X4Each independently selected from N or CRx1;X5To X8Each independently selected from N, C or CRx2And X5To X8Two of them are adjacent to each other and are randomly connected with the positions shown by two in the formula 1A;
Figure FDA0002262103940000012
wherein L isxIs a single bond, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms, or a substituted or unsubstituted heteroarylene group having 3 to 30 carbon atoms;
wherein Z is1To Z4Each independently selected from N, C or CRz
Wherein each occurrence of Ar, the same or different, is selected from substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, or substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms;
wherein the adjacent substituents Rx1Can optionally be linked to form a ring;
wherein R isx1,Rx2,Ry,RzAnd R is selected, identically or differently on each occurrence, from the group consisting of: hydrogen, deuterium, halogen, a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 ring carbon atoms, a substituted or unsubstituted heteroalkyl group having 1 to 20 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, substituted or unsubstituted amine, acyl, carbonyl groups having 0 to 20 carbon atomsCarboxylic acid groups, ester groups, cyano groups, isocyano groups, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof.
2. The compound of claim 1, represented by any one of formula 2-1 to formula 2-6:
Figure FDA0002262103940000021
Figure FDA0002262103940000031
wherein, Y1To Y8,X1To X8,Z1To Z4,R,Ar,LxAnd LyAll having the same limitations as defined in claim 1.
3. The compound of claim 1 or 2, represented by any one of formulae 2-7 to formulae 2-12:
Figure FDA0002262103940000041
Figure FDA0002262103940000051
wherein, Y1,Y5To Y8,X1To X8,Z1To Z4,R,Ar,LxAnd LyAll having the same limitations as defined in claim 1.
4. A compound according to any one of claims 1 to 3, wherein Y is1,Y5To Y8Each independently selected from CRyWherein R isyEach occurrence being selected identically or differently fromThe group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
5. A compound according to any one of claims 1 to 3, wherein X1To X4Each independently selected from CRX1,X5-X8Two of which are adjacent and selected from C, the remaining two are each independently selected from CRX2Wherein R isx1And Rx2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof.
6. A compound according to any one of claims 1 to 3, wherein Z is1To Z4One of which is selected from C and the others are each independently selected from N or CRzWherein R iszEach occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl having 3 to 30 carbon atoms, and
combinations thereof.
7. A compound according to any one of claims 1 to 3, wherein Y is1,Y5To Y8Each independently selected from CRy
X1To X4Each independently selected from CRx1,X5-X8Two of them are adjacent and selected from C, and the other two are each independently selected from CRx2
Z1To Z4One of which is selected from C and the others are each independently selected from CRz
Ry,Rx1,Rx2And RzThe same or different at each occurrence is selected from the group consisting of: hydrogen, deuterium, substituted or unsubstituted aryl radicals having 6 to 30 carbon atoms, substituted or unsubstituted aryl radicals havingHeteroaryl of 3 to 30 carbon atoms, and combinations thereof.
8. A compound according to any one of claims 1 to 3, wherein LxAnd LyEach independently selected from the group consisting of a single bond, a substituted or unsubstituted arylene group having 6 to 12 carbon atoms, a substituted or unsubstituted heteroarylene group having 3 to 12 carbon atoms; preferably, LxAnd LyEach independently selected from a single bond, or a substituted or unsubstituted phenylene group.
9. A compound according to any one of claims 1 to 3, wherein R, identically or differently on each occurrence, is selected from substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, and combinations thereof; preferably, R is selected, identically or differently on each occurrence, from the group consisting of: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, phenyl, and combinations thereof.
10. A compound according to any one of claims 1 to 3, wherein each occurrence of Ar, which is the same or different, is selected from the group consisting of: a substituted or unsubstituted phenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzothiapyrrolyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or unsubstituted dibenzoselenophenyl group, and combinations thereof; preferably, Ar is selected, identically or differently at each occurrence, from the group consisting of: phenyl, biphenyl, pyridyl, cyanophenyl, fluorenyl, dimethylfluorenyl, diphenylfluorenyl, carbazolyl, phenylcarbazolyl, dibenzothiapyrrolyl, dimethyldibenzothiapyrrolyl, diphenyldibenzothiapyrrolyl, biphenyl, terphenyl, phenanthrenyl, triphenylene, spirobifluorenyl, dibenzofuranyl, dibenzothiophenyl, dibenzoselenophenyl, azadibenzofuranyl, azadibenzothiophenyl, azadibenzoselenophenyl, and combinations thereof.
11. The compound of claim 1, wherein the compound comprising formula 1 is selected from the group consisting of:
Figure FDA0002262103940000071
Figure FDA0002262103940000081
Figure FDA0002262103940000091
Figure FDA0002262103940000101
Figure FDA0002262103940000111
Figure FDA0002262103940000121
Figure FDA0002262103940000131
Figure FDA0002262103940000141
Figure FDA0002262103940000151
Figure FDA0002262103940000161
Figure FDA0002262103940000171
Figure FDA0002262103940000181
Figure FDA0002262103940000191
Figure FDA0002262103940000201
Figure FDA0002262103940000211
Figure FDA0002262103940000221
Figure FDA0002262103940000231
Figure FDA0002262103940000241
Figure FDA0002262103940000251
Figure FDA0002262103940000261
Figure FDA0002262103940000271
Figure FDA0002262103940000281
Figure FDA0002262103940000291
Figure FDA0002262103940000301
Figure FDA0002262103940000311
Figure FDA0002262103940000321
Figure FDA0002262103940000331
Figure FDA0002262103940000341
Figure FDA0002262103940000351
Figure FDA0002262103940000361
Figure FDA0002262103940000371
Figure FDA0002262103940000381
Figure FDA0002262103940000391
Figure FDA0002262103940000401
Figure FDA0002262103940000411
Figure FDA0002262103940000421
Figure FDA0002262103940000431
Figure FDA0002262103940000441
Figure FDA0002262103940000451
Figure FDA0002262103940000461
Figure FDA0002262103940000471
Figure FDA0002262103940000481
Figure FDA0002262103940000491
Figure FDA0002262103940000501
Figure FDA0002262103940000511
Figure FDA0002262103940000521
Figure FDA0002262103940000531
Figure FDA0002262103940000541
12. an electroluminescent device, comprising:
an anode, a cathode, a anode and a cathode,
a cathode electrode, which is provided with a cathode,
and an organic layer disposed between the anode and cathode, the organic layer comprising the compound of claim 1.
13. The device of claim 12, wherein the organic layer is an emissive layer and the compound is a host material.
14. The device of claim 13, wherein the light emitting layer further comprises a phosphorescent light emitting material;
preferably, wherein the phosphorescent light-emitting material is a metal complex comprising at least one ligand comprising the structure of any one of:
Figure FDA0002262103940000551
wherein the content of the first and second substances,
Xbselected from the group consisting of: o, S, Se, NRN1And CRC1RC2
XcAnd XdEach independently selected from the group consisting of: o, S, Se and NRN2
Ra,RbAnd RcMay represent mono-, poly-, or unsubstituted, and may be the same or different at each occurrence;
Ra,Rb,Rc,RN1,RN2,RC1and RC2Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl having 1 to 20 carbon atoms, substituted or unsubstituted heteroalkyl having 7-an aralkyl group of 30 carbon atoms, a substituted or unsubstituted alkoxy group having 1 to 20 carbon atoms, a substituted or unsubstituted aryloxy group having 6 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 20 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl group having 3 to 20 carbon atoms, a substituted or unsubstituted arylsilyl group having 6 to 20 carbon atoms, a substituted or unsubstituted amine group having 0 to 20 carbon atoms, an acyl group, a carbonyl group, a carboxylic acid group, an ester group, a nitrile, an isonitrile, a thio group, a sulfinyl group, a sulfonyl group, a phosphino group, and combinations thereof;
in the ligand structure, adjacent substituents can optionally be linked to form a ring.
15. An electroluminescent device as claimed in claim 14 wherein the phosphorescent light emitting material is an Ir, Pt or Os complex;
preferably, wherein the phosphorescent light-emitting material is an Ir complex and has Ir (L)a)(Lb)(Lc) In which La,LbAnd LcLigands, identically or differently, selected from any of the above;
preferably, wherein the phosphorescent light emitting material is selected from the group consisting of:
Figure FDA0002262103940000552
Figure FDA0002262103940000561
wherein, XfEach occurrence, the same or different, is selected from the group consisting of: o, S, Se, NRN3And CRC3RC4
Wherein, XeSelected from CR, identically or differently at each occurrencedOr N;
Ra,Rband RcMay represent mono-, poly-, or unsubstituted, and may be the same or different at each occurrence;
Ra,Rb,Rc,Rd,RN3,RC3and RC4Each occurrence, the same or different, is selected from the group consisting of: hydrogen, deuterium, halogen, substituted or unsubstituted alkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted cycloalkyl groups having 3 to 20 ring carbon atoms, substituted or unsubstituted heteroalkyl groups having 1 to 20 carbon atoms, substituted or unsubstituted aralkyl groups having 7 to 30 carbon atoms, substituted or unsubstituted alkoxy groups having 1 to 20 carbon atoms, substituted or unsubstituted aryloxy groups having 6 to 30 carbon atoms, substituted or unsubstituted alkenyl groups having 2 to 20 carbon atoms, substituted or unsubstituted aryl groups having 6 to 30 carbon atoms, substituted or unsubstituted heteroaryl groups having 3 to 30 carbon atoms, substituted or unsubstituted alkylsilyl groups having 3 to 20 carbon atoms, substituted or unsubstituted arylsilyl groups having 6 to 20 carbon atoms, substituted or unsubstituted amine groups having 0 to 20 carbon atoms, acyl groups, carbonyl groups, carboxylic acid groups, ester groups, nitriles, isonitriles, thio groups, sulfinyl groups, sulfonyl groups, phosphino groups, and combinations thereof,
adjacent substituents can optionally be joined to form a ring.
16. A compound formulation comprising the compound of claim 1.
CN201911084832.5A 2019-11-08 2019-11-08 Organic electroluminescent material and device thereof Active CN112778283B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911084832.5A CN112778283B (en) 2019-11-08 2019-11-08 Organic electroluminescent material and device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911084832.5A CN112778283B (en) 2019-11-08 2019-11-08 Organic electroluminescent material and device thereof

Publications (2)

Publication Number Publication Date
CN112778283A true CN112778283A (en) 2021-05-11
CN112778283B CN112778283B (en) 2023-02-03

Family

ID=75748104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911084832.5A Active CN112778283B (en) 2019-11-08 2019-11-08 Organic electroluminescent material and device thereof

Country Status (1)

Country Link
CN (1) CN112778283B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113336785A (en) * 2021-06-25 2021-09-03 长春海谱润斯科技股份有限公司 Aromatic amine compound containing silafluorene and organic electroluminescent device thereof
CN113620858A (en) * 2020-12-14 2021-11-09 阜阳欣奕华材料科技有限公司 Organic electroluminescent compound and preparation method and application thereof
CN113968811A (en) * 2021-11-16 2022-01-25 阜阳欣奕华材料科技有限公司 Indenocarbazole organic compound and application thereof
CN113980006A (en) * 2021-11-16 2022-01-28 阜阳欣奕华材料科技有限公司 Indenocarbazole organic compound and application thereof
US12030875B2 (en) 2019-09-06 2024-07-09 PIC Therapeutics, Inc. EIF4E inhibitors and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105849107A (en) * 2013-12-27 2016-08-10 罗门哈斯电子材料韩国有限公司 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
CN106046006A (en) * 2015-04-06 2016-10-26 环球展览公司 Organic electroluminescent materials and devices
CN106458997A (en) * 2014-05-08 2017-02-22 罗门哈斯电子材料韩国有限公司 An electron transport material and an organic electroluminescence device comprising the same
CN108779072A (en) * 2016-03-14 2018-11-09 株式会社Lg化学 Heterocyclic compound and organic illuminating element comprising it
CN109694368A (en) * 2017-10-20 2019-04-30 北京夏禾科技有限公司 Indole carbazole neighbours Asia benzene compound
CN109928885A (en) * 2017-12-19 2019-06-25 北京夏禾科技有限公司 Neighbours Asia benzene triarylamine compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105849107A (en) * 2013-12-27 2016-08-10 罗门哈斯电子材料韩国有限公司 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
CN106458997A (en) * 2014-05-08 2017-02-22 罗门哈斯电子材料韩国有限公司 An electron transport material and an organic electroluminescence device comprising the same
CN106046006A (en) * 2015-04-06 2016-10-26 环球展览公司 Organic electroluminescent materials and devices
CN108779072A (en) * 2016-03-14 2018-11-09 株式会社Lg化学 Heterocyclic compound and organic illuminating element comprising it
CN109694368A (en) * 2017-10-20 2019-04-30 北京夏禾科技有限公司 Indole carbazole neighbours Asia benzene compound
CN109928885A (en) * 2017-12-19 2019-06-25 北京夏禾科技有限公司 Neighbours Asia benzene triarylamine compounds

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12030875B2 (en) 2019-09-06 2024-07-09 PIC Therapeutics, Inc. EIF4E inhibitors and uses thereof
CN113620858A (en) * 2020-12-14 2021-11-09 阜阳欣奕华材料科技有限公司 Organic electroluminescent compound and preparation method and application thereof
CN113336785A (en) * 2021-06-25 2021-09-03 长春海谱润斯科技股份有限公司 Aromatic amine compound containing silafluorene and organic electroluminescent device thereof
CN113968811A (en) * 2021-11-16 2022-01-25 阜阳欣奕华材料科技有限公司 Indenocarbazole organic compound and application thereof
CN113980006A (en) * 2021-11-16 2022-01-28 阜阳欣奕华材料科技有限公司 Indenocarbazole organic compound and application thereof
CN113980006B (en) * 2021-11-16 2023-08-04 阜阳欣奕华材料科技有限公司 Indenocarbazole organic compound and application thereof

Also Published As

Publication number Publication date
CN112778283B (en) 2023-02-03

Similar Documents

Publication Publication Date Title
CN109422770B (en) Boron-containing heterocyclic compounds for OLEDs, organic light emitting devices, and compound formulations comprising the same
CN109422666B (en) Hole injection layer and charge generation layer containing a truxene-based compound
CN111518139A (en) Organic luminescent material containing cyano-substituted ligand
CN109694368B (en) Indolocarbazole tetraphthalene compounds
CN109651065B (en) Tetraortho-phenylene anthracene compounds
CN111675697B (en) Organic electroluminescent material and device thereof
CN112876489B (en) Organic electroluminescent material and device thereof
CN111196822A (en) Compound containing silicon fluorenyl and fluorenyl structures and electroluminescent device containing compound
CN109928885B (en) Tetraortho-phenylene triarylamine compounds
CN111675698B (en) Organic electroluminescent material and device thereof
CN112778283B (en) Organic electroluminescent material and device thereof
CN109836435B (en) Triarylamine compounds containing thiophene
CN109796499B (en) Metal complexes of azabenzothiazoles containing nitrogen
CN111620853A (en) Organic electroluminescent material and device thereof
CN113527316A (en) Electroluminescent material and device
CN115073501A (en) Organic electroluminescent material and device thereof
CN113968875A (en) Electroluminescent material and device
CN113527315A (en) Electroluminescent material and device
CN111333611B (en) Organic electroluminescent material and device thereof
CN111100129B (en) Organic electroluminescent material and device
CN109575085B (en) Organic luminescent material containing tetra-ortho-phenylene ligand
CN112390780B (en) Electron transport material containing nitrogen hetero-spirobifluorene
CN113527317A (en) Electroluminescent material and device
CN113278033A (en) Organic electroluminescent material and device
CN112430191A (en) Pyrene compound containing aromatic amine substitution

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant